Screening and Treatment of Retinopathy of Prematurity - clinical guideline

This evidence-based guideline for the screening and treatment of retinopathy of prematurity (ROP) was developed by the RCPCH in collaboration with the Royal College of Ophthalmologists, British Association of Perinatal Medicine and BLISS.

ROP is one of the few causes of childhood visual disability that is largely preventable. Many extremely preterm babies will develop some degree of ROP although in the majority this never progresses beyond mild disease which resolves spontaneously without treatment. A small proportion develop potentially severe ROP which can be detected through retinal screening. If untreated, severe disease can result in serious vision impairment and consequently all babies at risk of sight-threatening ROP should be screened.

The current guideline and parent information was published in 2008, and reviewed in 2013.

The RCPCH and Royal College of Ophthalmologists (RCOphth) are now updating this in two parts: the RCPCH are updating the screening of ROP (the scope can be downloaded below), and the RCOphth are updating the guideline on the treatment of ROP. The two Colleges are working closely to ensure the updated guidelines are synchronised, and we expect to publish in early 2022.